SlideShare a Scribd company logo
Immunodeficiency
Disorders- Tutorials
Presenter- Dr. Bishal Gupta
Moderator- Dr. Chinmoy Sahu
Date- 27.01.2023
Introduction
• Immunodeficiency - state where the defence mechanisms of the body are impaired,
leading to enhanced susceptibility to microbial infections as well as to certain forms of
cancer
• Immunodeficiency diseases are broadly classified as:
Primary immunodeficiency
Secondary immunodeficiency
Humoral immunodeficiency (B cell defects)
 Bruton disease (X-linked
agammaglobulinemia)
 Common variable immunodeficiency
 Isolated IgA deficiency
 Hyper-IgM syndrome
Cellular immunodeficiencies (T cell defects)
 DiGeorge syndrome (thymic hypoplasia)
 Chronic mucocutaneous candidiasis
 Purine nucleoside phosphorylase (PNP)
deficiency
Disorders of complement
 Complement component deficiencies
 Complement regulatory protein deficiencies
Combined immunodeficiencies (B and T cell
defects)
 Severe combined immunodeficiencies
• Cytokine receptor mutation
• Adenosine deaminase (ADA) deficiency
 Wiskott–Aldrich syndrome
 Ataxia telangiectasia
 Nezelof syndrome
Disorders of phagocytosis
 Chronic granulomatous disease
 Myeloperoxidase deficiency
 Chediak–Higashi syndrome
 Leukocyte adhesion deficiency
 Lazy leukocyte syndrome
 Job’s syndrome or Hyper-IgE syndrome
Bruton Disease (X-linked
Agammaglobulinemia)
• Failure of pre-B cells to differentiate into immature B cells in the bone marrow
• Due to absence of an enzyme called Bruton’s tyrosine kinase (transformation of pre-B cell
into immature B cell)  Total absence of B cells and plasma cells in the circulation
• Pre-B cells are found in normal numbers in bone marrow and the T-cell-mediated
responses are also normal
• Cytoplasm of pre B cell may have incomplete immunoglobulins
• X linked, primarily in males; nevertheless, sporadic cases have been described in females
• Secondary infections are seen after 6 months of age, when maternal antibodies are
depleted
Recurrent bacterial infections (e.g., Haemophilus influenzae, Streptococcus
pneumoniae, or Staphylococcus aureus) leading to acute and chronic pharyngitis,
sinusitis, otitis media, bronchitis, and pneumonia
Viruses that are cleared by neutralizing antibodies- e.g. enteroviruses
Parasites which are usually resisted by secretory IgA- e.g. Giardia lamblia
Common Variable Immunodeficiency
• Heterogeneous group of both sporadic and inherited forms of the disease
• Hypogammaglobulinemia, increased susceptibility to infection, autoimmune disorders
(hemolytic anemia, pernicious anemia), as well as lymphoid tumors
• Clinical manifestations are superficially similar to those of Bruton diseases; but differ in
the following aspects:
Both sexes are affected equally
Onset of symptoms is much later - second or third decade of life
B cell development defect
Intrinsic B-cell defects, deficient T-cell help, or excessive T-cell suppressor activity
Isolated IgA Deficiency
• Most common, affects about 1 in 700 white individuals
• Weakened mucosal defences due to IgA deficiency predispose patients to recurrent
sinopulmonary infections and diarrhea
• Significant (but unexplained) association with autoimmune diseases
• Pathogenesis:
 Block in the terminal differentiation of IgA-secreting B cells to plasma cells (due to altered T-
cell production of cytokines or intrinsic B-cell defect)
The levels of other immunoglobulins are usually normal or even excess
Hyper-IgM Syndrome
• X-linked disorder - due to a defect in isotype class switchover of B cells
• Mutations in either CD40L or CD40 genes, leading to prevention of interaction between T and B-cell ; thus
blocking the class switchover
• Block in class switchover results in lack of synthesis of other classes of antibodies - IgG, IgA, and IgE with a
normal or supernormal levels of IgM
• Deficiency of IgG – leads to defect in opsonization and complement activation (predisposes to recurrent
pyogenic infections)
Hyper-IgM Syndrome
• IgA deficiency leads to increased recurrent sinopulmonary infections
and diarrhea
• Excess IgM antibodies can react with blood cells, resulting in
autoimmune hemolytic anemia, thrombocytopenia, or neutropenia
• Patients with defect in CD40L are more susceptible to Pneumocystis
jirovecii infection
DiGeorge Syndrome (Thymic Aplasia)
• Results from a congenital defect in thymic development leading to defect in T-cell
maturation
• Infants are extremely vulnerable to viral, fungal, intracellular bacterial and protozoan
infections
• Pathogenesis- In 90% of cases, there occurs a deletion affecting chromosome 22q11
which leads to developmental malformation affecting the third and fourth pharyngeal
pouches in embryonic life
• Thymus, parathyroid glands, and portions of the face and aortic arch become defective
DiGeorge Syndrome (Thymic Aplasia)
• There may be associated:
Parathyroid gland hypoplasia resulting in neonatal tetany and hypocalcemia
Anomalies of the heart and the great vessels (Fallot's Tetralogy)
Characteristic facial appearance
• Treatment- Thymus transplantation has been found to be successful in restoration of
immune function. In others (with partial defects), immunity may improve spontaneously
with age
• CATCH 22
Chronic Mucocutaneous Candidiasis
• Represents an impaired cell-mediated immunity against Candida albicans
leads to superficial infections of the skin, mucous membranes, and nails
• Do not show increased susceptibility to other infections but often
associated with endocrinopathies and autoimmune disorders (vitiligo,
malabsorption syndromes)
• Transfer factor therapy, along with fluconazole has been reported to be
effective
Severe Combined Immunodeficiencies
(SCID)
• Represents groups of genetically distinct syndromes; all having in common,
defects in both humoral and cell-mediated immune responses
• Severe: implies complete absence of T cell function, death in first year
• Mutation in cytokine receptor - Approximately 50-60% of the cases of SCID
are X-linked (seen in males)
• Results from mutations in the gene encoding the common γ chain shared
by the cytokine receptors for IL-7 and others (IL-2, IL-4, IL-9, and IL-15)
• Defective IL-7 receptor - defect in survival and expansion of immature B-
and T-cell precursors in the bone marrow
• Defect in IL-15 receptor - deficiency of NK cell
Types of SCID
• Adenosine deaminase (ADA) deficiency - Most common, ADA deficiency leads to accumulation of
deoxyadenosine which is toxic to rapidly dividing immature T lymphocytes
• RAG Mutation- Recombinase-activating genes (RAG) defect blocks the development of T and B
cells
• Jak3 mutation- Jak3, an intracellular kinase mutation is another way of blocking the cytokine
receptor signalling
• Class II MHC deficiency-Mutations that impair the expression of class II MHC molecules prevent
the development of CD4+ T cells. This condition is also called the bare lymphocyte syndrome
SCID
• Affected infants are susceptible to
severe recurrent infections by a wide
array of pathogens, including Candida,
Pneumocystis, cytomegalovirus, and
Pseudomonas
• Bone marrow transplantation. Gene
therapy replacing the mutated genes
has been successful in X linked cases
Wiskott–Aldrich Syndrome (WAS)
• X-linked recessive disease
• Characterized by immunodeficiency with thrombocytopenia, eczema(triad)
• Severity of WAS increases with age
• First manifests itself by defective responses to bacterial polysaccharides and by lower IgM levels.
IgG levels are usually normal
Paradoxically the levels of IgA and IgE are often elevated
• Other T and B cell responses are normal initially, but with increase of age, there are recurrent
bacterial infections and a gradual loss of humoral and cellular responses
• Prone to develop non-Hodgkin B-cell lymphomas
• Bloody diarrhea secondary to thrombocytopenia
Wiskott–Aldrich Syndrome (WAS)
• Pathogenesis:
Genetic defect is due to a mutation in the gene encoding Wiskott-Aldrich syndrome
protein (WASP) present in precursor lymphoid cells of bone marrow
Cytoskeletal glycoprotein (sialophorin or CD43), required for actin polymerization
Ataxia Telangiectasia
• Difficulty in maintaining balance while walking (cerebellar ataxia)
• Appearance of broken capillaries (telangiectasia) in the eyes and
choreoathetoid movements (usually noticed in infancy)
• Deficiency of IgA and sometimes IgE
• Profound sinopulmonary infections
• Primary defect - kinase involved in regulation of the cell cycle
Nezelof Syndrome
• Autosomal recessive
• Cellular immunodeficiency resulting from thymus hypoplasia
• In some patients, B cells are normal, whereas in others a B-cell
deficiency is secondary to the T-cell defect
• Affected individuals suffer from chronic diarrhea, viral and fungal
infections, and a general failure to thrive
Chronic Granulomatous Disease (CGD)
• Pathogenesis:
Involves inherited defects in the gene encoding components of oxidase
system
E.g. Nicotinamide adenine dinucleotide phosphate (NADP) oxidase of
phagocyte which breaks down hydrogen peroxide to generate free oxygen
radicals (O2
-) that are involved in microbial killing
Decreased oxidative burst which predisposes to recurrent bacterial infections.
CGD is a genetic disease that runs in family in two forms
• X linked form (more common, 70%) - membrane component of phagocyte
oxidase is defective
• Autosomal recessive form- cytoplasmic component of phagocyte oxidase is
defective
Chronic Granulomatous Disease (CGD)
• Manifestations-
Bacteria involved in the recurrent infections are catalase positive; pyogenic
pathogens such as staphylococci, Pseudomonas and coliforms
Excessive inflammatory reactions that result in gingivitis, swollen lymph nodes, and
non-malignant granulomas (lumpy subcutaneous cell masses)
Nitroblue tetrazolium reduction test (NBT) is used for screening to detect deficiency
of NADPH oxidase activity
Myeloperoxidase Deficiency
• Common genetic disorder characterized by deficiency in either
quantity or function, of myeloperoxidase, an enzyme produced by
neutrophils
• Patients present with immune deficiency and recurrent infections,
especially with Candida albicans
Chediak–Higashi Syndrome
• Autosomal recessive disease
• Defective fusion of phagosomes and lysosomes in phagocytes which leads to
increased susceptibility to recurrent and severe pyogenic infections
• Abnormalities in melanocytes leading to albinism (lack of skin and eye pigment)
• Abnormalities in cells of the nervous system (associated with nerve defects), and
• Platelets abnormalities, causing bleeding disorders
• Aggressive but non-malignant infiltration of organs by lymphoid cells
Chediak–Higashi Syndrome
• Pathogenesis:
Mutation in a protein called LYST (regulate lysosomal trafficking)
 Impairs the targeting of proteins to secretory lysosomes, which makes them unable
to lyse bacteria
 Phagocytes from patients with this immune defect contain giant granules but do not
have the ability to kill bacteria
Leukocyte Adhesion Deficiency (LAD)
• Rare autosomal recessive disorder, characterized by a defect in the
adhesion of leukocytes which results in poor leukocyte chemotaxis
particularly of neutrophils
• Predisposes to various bacterial and fungal infections
• Due to mutations in β2 integrin subunit (CD18) of the leukocyte cell
adhesion molecule or fucosyltransferase enzyme
Lazy Leukocyte Syndrome
• Idiopathic condition due to defect in neutrophil chemotaxis
• Increased pyogenic infections such as gingivitis, abscess formation,
pneumonia and neutropenia
Job’s Syndrome (Hyper-IgE Syndrome)
• Hyper-IgE syndrome - rare primary immunodeficiency disease
characterized by eczema, recurrent staphylococcal skin abscesses,
recurrent lung infections (pneumatocele), eosinophilia and high
serum levels of IgE
• Underlying mechanism - defect in neutrophil chemotaxis; due to
mutations in STAT3 or DOCK8 genes
SECONDARY IMMUNODEFICIENCIES
• Secondary effects of other diseases such as-
Malnutrition (due to inadequate immunoglobulin synthesis)
Aging (suppression of immune system with age)
Patients with several infections that supresses immune system causing lymphocyte
depletion, e.g. HIV (human immunodeficiency virus) infection.
Underlying cancers (particularly those of the bone marrow and blood cells (leukemia,
lymphoma, multiple myeloma)
Underlying proteinuric renal diseases– leads to loss of immunoglobulins
Sarcoidosis
Patients on immunosuppressive medications
Patients receiving chemotherapy or radiation therapy for malignancy
Pathogen Type T-Cell Defect B-Cell Defect Granulocyte
Defect
Complement
Defect
Bacteria Bacterial sepsis Streptococci,
Staphylococci,
Haemophilus
influenzae
Staphylococci,
Pseudomonas
Nocardia
Neisseria,
Other pyogenic
infections
Viruses Cytomegalovirus,
Epstein-Barr virus,
Severe varicella,
Chronic infections
with respiratory
and intestinal
viruses
Enterovirus
encephalitis
-
Fungi Candida,
Pneumocystis
- Candida,
Aspergillus
Pathogen Type T-Cell Defect B-Cell Defect Granulocyte Defect Complement Defect
Parasites - Giardiasis -
Special features Aggressive disease
with opportunistic
pathogens, failure to
clear infections
Recurrent
sinopulmonary
infections,
Sepsis, chronic
meningitis
-
Case1
• 42 / male from Balrampur, Uttar Pradesh was cough and breathlessness since 6 months
• He had a history of taking anti tubercular therapy 15 years ago but there was no documentation
• He had no history of COVID-19 illness
• There was no history of diabetes,hypertension, ischaemic heart disease
• Patient was smoker for 20 years,quit smoking 5 years ago
• He is farmer by occupation
• CT guided biopsy of the mass lesion (done on 1/7/22) was done outside and was suggestive of
fungal granuloma , while work up for TB was negative
• Patent was initiated on empirical anti-fungals (Fluconazole 400mg/day); which he has taken for 4
months- however there is no clinic-radiological improvement. He was thus referred to Dept. of
Pulmonary Medicine at our hospital
Figure showing CT Thorax- homogenous soft tissue
lesion in the right upper lobe, right middle lobe, and
superior segment of RLL with non enhancing
necrotic component
Figure showing Chest Xray with lobulated
spiculated mass covering upper and middle lobe
Work up
• Repeat CT guided biopsy was done and the biopsy sample was sent to microbiology department for further
confirmation
• Mycobacterium tuberculosis complex was not detected by GeneXpert Assay. ZN stain was negative for acid
fast bacilli. Culture for tuberculosis was also negative
• 10% KOH wet shows plenty of tissue debris and plenty capsulated round budding yeast suggestive of
Cryptococcus spp
• Grams’s stain also showed 5-10 micrometer round double walled spherical structures with gram positive
stippling suggestive of Cryptococcus spp
• However culture was negative after 6 weeks of incubation
Figure showing 10% KOH preparation of
lung tissue round yeast cells(yellow arrow)
Figure showing Gram’s stain- 5-10 micrometer round
double walled spherical structures with gram positive
stippling (yellow arrow)
Figure showing cryptococcal antigen from lung tissue sample
with titre 1:8
Further Work up
• HIV 1 and 2- Not detected
• HbsAg- Not detected
• Anti HCV-Not detected
• Serum IgA-324 mg/dl (Normal range 90-450 mg/dl)
• Serum IgE- 1799 iu/ml
• Serum IgM- 82.3 mg/dl (Normal range 60-280 mg/dl)
• Serum IgG= 1630 mg/dl (Normal range 800-1800 mg/dl)
• His absolute CD4 count was 173 per cmm. Suggestive of CD4
lymphopenia
• Final Diagnosis- Lung mass caused by Cryptococcus spp in a patient
of isolated CD4 lymphopenia.
• Total Duration of Illness – 2 years
• Dec 2020: Fever, cough for 1 week
• Jan 2021: Fever, cough, shoertness of breath treated
as pneumonia with IV antibiotic for 1 month(Needed
hospital admission)
• Oct 2021: Fever, cough – admitted and treated 1 week
• Dec 2021: Petechial rash over bilateral hands, chest,
abdomen, no h/o mucosal lesions, reduced platelet. No
platelet transfusion was given. Symptoms resolved in 4
days
• April 2022: Fever, with raised TLC around 24000,
Treated for 2 days. Hb 7. Platelet – 33k. 1 PRBC was
transfused
• June 2022: 3 platelets transfused. BMA – Congenital
amegakaryocytic thrombocytopenia
• Aug-Sept 2022: On oral folate,
• Oct 2022: Thrombocytopenia, PLT – 33k. TLC 50,000.
TLC 26000, L 88, N8
• Two of his sibling died
Further Work up
• HIV 1 and 2- Not detected
• HbsAg- Not detected
• Anti HCV-Not detected
• Serum IgA-6.67 mg/dl (Normal range 90-450 mg/dl)
• Serum IgE- 5 iu/ml
• Serum IgM- 4.17 mg/dl (Normal range 60-280 mg/dl)
• Serum IgG= 33.3 mg/dl (Normal range 800-1800 mg/dl)
• Total lymphocytes: 68%,
• T cell- 97%, B cell - 0.01%, NK cell - 2%,
• Of the CD3+ T Cells:- CD4 positive T cells: 3%, CD8 Pos T Cells:
86%, DNTs- 11%.
CD4:CD8 ratio is 1:29
Case 3
• 27/ M from a site manager of fertilizer unit
• TDI – 2 yrs
• Aug 2020: Weight loss 1 yr – 13 kg, fever low grade 3 months, night
sweats, abdominal pain
• Started on emperical ATT (outside)
• ill defines hypodense lesions in spleen, minimal ascites,
retroperitoneal lymphadenopathy
• Patient started feeling well on ATT , fever resolved, there was weight
gain
• July 2021: Completed ATT for 1 yr
Present illness
• Nov 2022: 1 month history of cough with expectoration, myalgia,
fever low grade with loose stool for for 15 days
• CT thorax – multilobar bronchial wall thickening and mild dilatation
with clusters of branching centrilobular nodules in bilateral lower
lobes
• Multiple mediastinal, para tracheal and mesenteric nodes present
Course in SGPGIMS
• Admitted in SGPGIMS as a case of pneumonia
• He had leukopenia of 1900, ANC – 900
• Emperically started on cefoperazone- sulbactum and Teicoplanin
• He was afebrile after 3 days
• His sputum revealed Pseudomonas aeruninosa
• Gene Xpert sputum negative
• His lungs were clear. No active sputum or fever
• Hence Bone marrow analysis was done – BMA & Biopsy normal
• Stool examination- Giardia sp
Lymphocyte subset analysis
• low B cell count, normal NK, CD4, CD8, total T cell count
Further Work up
• HIV 1 and 2- Not detected
• HbsAg- Not detected
• Anti HCV-Not detected
• Serum IgA-6.67 mg/dl (Normal range 90-450 mg/dl)
• Serum IgE- 5 iu/ml
• Serum IgM- 8.08 mg/dl (Normal range 60-280 mg/dl)
• Serum IgG= 33.3 mg/dl (Normal range 800-1800 mg/dl)
• Final diagnosis- Common variable immunodeficiency
immunodef dis.pptx

More Related Content

What's hot

aspergillus lecture
aspergillus lectureaspergillus lecture
aspergillus lecture
R Lin
 
Chronic mucocutaneous candidiasis
Chronic mucocutaneous candidiasisChronic mucocutaneous candidiasis
Mycoplasma
MycoplasmaMycoplasma
Mycoplasma
Shilpa k
 
Mycosis
MycosisMycosis
Mycosis
hussain422
 
immunodeficiency
immunodeficiencyimmunodeficiency
immunodeficiency
Sher Khan
 
Bordetella
BordetellaBordetella
severe combined immunodeficiency syndrome
severe combined immunodeficiency syndromesevere combined immunodeficiency syndrome
severe combined immunodeficiency syndrome
Fatima Sayeed
 
Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) by Dr. Himanshu Khatri
Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) by Dr. Himanshu KhatriEpstein-Barr Virus (EBV) and Cytomegalovirus (CMV) by Dr. Himanshu Khatri
Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) by Dr. Himanshu Khatri
DrHimanshuKhatri
 
Selective ig a deficiency
Selective ig a deficiencySelective ig a deficiency
Selective ig a deficiencyFatima Awadh
 
X linked agammaglobulinemia
X linked agammaglobulinemiaX linked agammaglobulinemia
Immunodeficiency Syndrome
Immunodeficiency SyndromeImmunodeficiency Syndrome
Immunodeficiency Syndrome
Hadi Munib
 
Pneumococcus (microbiology)
Pneumococcus (microbiology)Pneumococcus (microbiology)
Pneumococcus (microbiology)
MrVermaasahab
 
Host microbial interaction part 1
Host microbial interaction part 1 Host microbial interaction part 1
Host microbial interaction part 1
Ashish Bisane
 
Zygomycosis
ZygomycosisZygomycosis
Zygomycosis
Amjad Afridi
 
Aspergillosis
AspergillosisAspergillosis
Aspergillosis
VarshiniS27
 
COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)
Abdullatif Al-Rashed
 
Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015
Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015
Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015
SOMESHWARAN R
 

What's hot (20)

aspergillus lecture
aspergillus lectureaspergillus lecture
aspergillus lecture
 
Chronic mucocutaneous candidiasis
Chronic mucocutaneous candidiasisChronic mucocutaneous candidiasis
Chronic mucocutaneous candidiasis
 
Mycology
MycologyMycology
Mycology
 
Mycoplasma
MycoplasmaMycoplasma
Mycoplasma
 
Mycosis
MycosisMycosis
Mycosis
 
Clostridia
ClostridiaClostridia
Clostridia
 
immunodeficiency
immunodeficiencyimmunodeficiency
immunodeficiency
 
Bordetella
BordetellaBordetella
Bordetella
 
severe combined immunodeficiency syndrome
severe combined immunodeficiency syndromesevere combined immunodeficiency syndrome
severe combined immunodeficiency syndrome
 
Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) by Dr. Himanshu Khatri
Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) by Dr. Himanshu KhatriEpstein-Barr Virus (EBV) and Cytomegalovirus (CMV) by Dr. Himanshu Khatri
Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV) by Dr. Himanshu Khatri
 
Selective ig a deficiency
Selective ig a deficiencySelective ig a deficiency
Selective ig a deficiency
 
X linked agammaglobulinemia
X linked agammaglobulinemiaX linked agammaglobulinemia
X linked agammaglobulinemia
 
Hyper Ig M Syndrome
Hyper Ig M SyndromeHyper Ig M Syndrome
Hyper Ig M Syndrome
 
Immunodeficiency Syndrome
Immunodeficiency SyndromeImmunodeficiency Syndrome
Immunodeficiency Syndrome
 
Pneumococcus (microbiology)
Pneumococcus (microbiology)Pneumococcus (microbiology)
Pneumococcus (microbiology)
 
Host microbial interaction part 1
Host microbial interaction part 1 Host microbial interaction part 1
Host microbial interaction part 1
 
Zygomycosis
ZygomycosisZygomycosis
Zygomycosis
 
Aspergillosis
AspergillosisAspergillosis
Aspergillosis
 
COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)COMMON VARIABLE IMMUNODEFICIENCY (CVID)
COMMON VARIABLE IMMUNODEFICIENCY (CVID)
 
Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015
Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015
Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015
 

Similar to immunodef dis.pptx

Immunodeficiency diseases.pdf
Immunodeficiency diseases.pdfImmunodeficiency diseases.pdf
Immunodeficiency diseases.pdf
SreehariAP1
 
immunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathologyimmunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathology
makesharumugam23
 
immunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdfimmunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdf
SyedMuhammadZakria
 
Immunodeficiency (1)
Immunodeficiency (1)Immunodeficiency (1)
Immunodeficiency (1)
Sher Khan
 
Immunodeficiency
ImmunodeficiencyImmunodeficiency
Immunodeficiency
SajadAlfadul
 
IMMUNODEFICIENCY DISORDERS GROUP 6A.pptx
IMMUNODEFICIENCY DISORDERS GROUP 6A.pptxIMMUNODEFICIENCY DISORDERS GROUP 6A.pptx
IMMUNODEFICIENCY DISORDERS GROUP 6A.pptx
YvonneMwita
 
ranjithakm-180315143057.pdf
ranjithakm-180315143057.pdfranjithakm-180315143057.pdf
ranjithakm-180315143057.pdf
SyedMuhammadZakria
 
Immunodeficiency
ImmunodeficiencyImmunodeficiency
Immunodeficiency
RanjithaKM1
 
Primary immunodeficiency
Primary immunodeficiencyPrimary immunodeficiency
Primary immunodeficiency
Nishitha Ashok
 
Immunodeficiency disorders: inherited & acquired
Immunodeficiency disorders: inherited & acquiredImmunodeficiency disorders: inherited & acquired
Immunodeficiency disorders: inherited & acquired
OluwakemiTaiwo1
 
Pri & sec immuno deficiency
Pri & sec immuno deficiencyPri & sec immuno deficiency
Pri & sec immuno deficiency
Pooja Sevak
 
Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........
samwel18
 
Congenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyCongenital and Acquired Immunodeficiency
Congenital and Acquired Immunodeficiency
GifteeJRoumi
 
Immunodeficiencies.pptx
Immunodeficiencies.pptxImmunodeficiencies.pptx
Immunodeficiencies.pptx
OumaWinnie1
 
IMMUNODEFICIENCY DISEASES
IMMUNODEFICIENCY DISEASESIMMUNODEFICIENCY DISEASES
IMMUNODEFICIENCY DISEASES
VEENA P KUMAR
 
Immunodeficiencies.ppt
Immunodeficiencies.pptImmunodeficiencies.ppt
Immunodeficiencies.ppt
HaroonRiazRiaz
 
Immnunodeficiency
ImmnunodeficiencyImmnunodeficiency
Immnunodeficiency
Alicia Tiny
 
Primary immunodeficiencies
Primary immunodeficienciesPrimary immunodeficiencies
Primary immunodeficiencies
Sumudu Himesha Meawela
 
Immunology-Primary immunodeficiency disorders
Immunology-Primary immunodeficiency disordersImmunology-Primary immunodeficiency disorders
Immunology-Primary immunodeficiency disorders
Maryam Al-Maqrashi
 

Similar to immunodef dis.pptx (20)

Immunodeficiency diseases.pdf
Immunodeficiency diseases.pdfImmunodeficiency diseases.pdf
Immunodeficiency diseases.pdf
 
immunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathologyimmunodeficiency for mbbs students to ace in pathology
immunodeficiency for mbbs students to ace in pathology
 
immunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdfimmunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdf
 
Immunodeficiency (1)
Immunodeficiency (1)Immunodeficiency (1)
Immunodeficiency (1)
 
Immunodeficiency
ImmunodeficiencyImmunodeficiency
Immunodeficiency
 
IMMUNODEFICIENCY DISORDERS GROUP 6A.pptx
IMMUNODEFICIENCY DISORDERS GROUP 6A.pptxIMMUNODEFICIENCY DISORDERS GROUP 6A.pptx
IMMUNODEFICIENCY DISORDERS GROUP 6A.pptx
 
ranjithakm-180315143057.pdf
ranjithakm-180315143057.pdfranjithakm-180315143057.pdf
ranjithakm-180315143057.pdf
 
Immunodeficiency
ImmunodeficiencyImmunodeficiency
Immunodeficiency
 
Primary immunodeficiency
Primary immunodeficiencyPrimary immunodeficiency
Primary immunodeficiency
 
Immunopathology 4
Immunopathology 4Immunopathology 4
Immunopathology 4
 
Immunodeficiency disorders: inherited & acquired
Immunodeficiency disorders: inherited & acquiredImmunodeficiency disorders: inherited & acquired
Immunodeficiency disorders: inherited & acquired
 
Pri & sec immuno deficiency
Pri & sec immuno deficiencyPri & sec immuno deficiency
Pri & sec immuno deficiency
 
Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........Immunodeficiency_DISORDERS.pptx.........
Immunodeficiency_DISORDERS.pptx.........
 
Congenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyCongenital and Acquired Immunodeficiency
Congenital and Acquired Immunodeficiency
 
Immunodeficiencies.pptx
Immunodeficiencies.pptxImmunodeficiencies.pptx
Immunodeficiencies.pptx
 
IMMUNODEFICIENCY DISEASES
IMMUNODEFICIENCY DISEASESIMMUNODEFICIENCY DISEASES
IMMUNODEFICIENCY DISEASES
 
Immunodeficiencies.ppt
Immunodeficiencies.pptImmunodeficiencies.ppt
Immunodeficiencies.ppt
 
Immnunodeficiency
ImmnunodeficiencyImmnunodeficiency
Immnunodeficiency
 
Primary immunodeficiencies
Primary immunodeficienciesPrimary immunodeficiencies
Primary immunodeficiencies
 
Immunology-Primary immunodeficiency disorders
Immunology-Primary immunodeficiency disordersImmunology-Primary immunodeficiency disorders
Immunology-Primary immunodeficiency disorders
 

More from Chinmoy Sahu

scrub typhus.pptx
scrub typhus.pptxscrub typhus.pptx
scrub typhus.pptx
Chinmoy Sahu
 
CLSI 2021.pptx
CLSI 2021.pptxCLSI 2021.pptx
CLSI 2021.pptx
Chinmoy Sahu
 
PPT Measles & Rubella - Brief Presentation-03-05-2023 (2).ppt
PPT Measles & Rubella - Brief Presentation-03-05-2023 (2).pptPPT Measles & Rubella - Brief Presentation-03-05-2023 (2).ppt
PPT Measles & Rubella - Brief Presentation-03-05-2023 (2).ppt
Chinmoy Sahu
 
toxoplasma.pptx
toxoplasma.pptxtoxoplasma.pptx
toxoplasma.pptx
Chinmoy Sahu
 
Bertiellasis-an emerging zoonotic parasite.pptx
Bertiellasis-an emerging zoonotic parasite.pptxBertiellasis-an emerging zoonotic parasite.pptx
Bertiellasis-an emerging zoonotic parasite.pptx
Chinmoy Sahu
 
Beta lactamases.pptx
Beta lactamases.pptxBeta lactamases.pptx
Beta lactamases.pptx
Chinmoy Sahu
 
Nanotechnology and its application in clinical microbiology.pptx
Nanotechnology and its application in clinical microbiology.pptxNanotechnology and its application in clinical microbiology.pptx
Nanotechnology and its application in clinical microbiology.pptx
Chinmoy Sahu
 
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptx
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptxAntimicrobial Stewardship_Dr Chinmoy Sahu.pptx
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptx
Chinmoy Sahu
 

More from Chinmoy Sahu (8)

scrub typhus.pptx
scrub typhus.pptxscrub typhus.pptx
scrub typhus.pptx
 
CLSI 2021.pptx
CLSI 2021.pptxCLSI 2021.pptx
CLSI 2021.pptx
 
PPT Measles & Rubella - Brief Presentation-03-05-2023 (2).ppt
PPT Measles & Rubella - Brief Presentation-03-05-2023 (2).pptPPT Measles & Rubella - Brief Presentation-03-05-2023 (2).ppt
PPT Measles & Rubella - Brief Presentation-03-05-2023 (2).ppt
 
toxoplasma.pptx
toxoplasma.pptxtoxoplasma.pptx
toxoplasma.pptx
 
Bertiellasis-an emerging zoonotic parasite.pptx
Bertiellasis-an emerging zoonotic parasite.pptxBertiellasis-an emerging zoonotic parasite.pptx
Bertiellasis-an emerging zoonotic parasite.pptx
 
Beta lactamases.pptx
Beta lactamases.pptxBeta lactamases.pptx
Beta lactamases.pptx
 
Nanotechnology and its application in clinical microbiology.pptx
Nanotechnology and its application in clinical microbiology.pptxNanotechnology and its application in clinical microbiology.pptx
Nanotechnology and its application in clinical microbiology.pptx
 
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptx
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptxAntimicrobial Stewardship_Dr Chinmoy Sahu.pptx
Antimicrobial Stewardship_Dr Chinmoy Sahu.pptx
 

Recently uploaded

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 

immunodef dis.pptx

  • 1. Immunodeficiency Disorders- Tutorials Presenter- Dr. Bishal Gupta Moderator- Dr. Chinmoy Sahu Date- 27.01.2023
  • 2. Introduction • Immunodeficiency - state where the defence mechanisms of the body are impaired, leading to enhanced susceptibility to microbial infections as well as to certain forms of cancer • Immunodeficiency diseases are broadly classified as: Primary immunodeficiency Secondary immunodeficiency
  • 3.
  • 4. Humoral immunodeficiency (B cell defects)  Bruton disease (X-linked agammaglobulinemia)  Common variable immunodeficiency  Isolated IgA deficiency  Hyper-IgM syndrome Cellular immunodeficiencies (T cell defects)  DiGeorge syndrome (thymic hypoplasia)  Chronic mucocutaneous candidiasis  Purine nucleoside phosphorylase (PNP) deficiency Disorders of complement  Complement component deficiencies  Complement regulatory protein deficiencies Combined immunodeficiencies (B and T cell defects)  Severe combined immunodeficiencies • Cytokine receptor mutation • Adenosine deaminase (ADA) deficiency  Wiskott–Aldrich syndrome  Ataxia telangiectasia  Nezelof syndrome Disorders of phagocytosis  Chronic granulomatous disease  Myeloperoxidase deficiency  Chediak–Higashi syndrome  Leukocyte adhesion deficiency  Lazy leukocyte syndrome  Job’s syndrome or Hyper-IgE syndrome
  • 5. Bruton Disease (X-linked Agammaglobulinemia) • Failure of pre-B cells to differentiate into immature B cells in the bone marrow • Due to absence of an enzyme called Bruton’s tyrosine kinase (transformation of pre-B cell into immature B cell)  Total absence of B cells and plasma cells in the circulation • Pre-B cells are found in normal numbers in bone marrow and the T-cell-mediated responses are also normal • Cytoplasm of pre B cell may have incomplete immunoglobulins • X linked, primarily in males; nevertheless, sporadic cases have been described in females
  • 6. • Secondary infections are seen after 6 months of age, when maternal antibodies are depleted Recurrent bacterial infections (e.g., Haemophilus influenzae, Streptococcus pneumoniae, or Staphylococcus aureus) leading to acute and chronic pharyngitis, sinusitis, otitis media, bronchitis, and pneumonia Viruses that are cleared by neutralizing antibodies- e.g. enteroviruses Parasites which are usually resisted by secretory IgA- e.g. Giardia lamblia
  • 7. Common Variable Immunodeficiency • Heterogeneous group of both sporadic and inherited forms of the disease • Hypogammaglobulinemia, increased susceptibility to infection, autoimmune disorders (hemolytic anemia, pernicious anemia), as well as lymphoid tumors • Clinical manifestations are superficially similar to those of Bruton diseases; but differ in the following aspects: Both sexes are affected equally Onset of symptoms is much later - second or third decade of life B cell development defect Intrinsic B-cell defects, deficient T-cell help, or excessive T-cell suppressor activity
  • 8. Isolated IgA Deficiency • Most common, affects about 1 in 700 white individuals • Weakened mucosal defences due to IgA deficiency predispose patients to recurrent sinopulmonary infections and diarrhea • Significant (but unexplained) association with autoimmune diseases • Pathogenesis:  Block in the terminal differentiation of IgA-secreting B cells to plasma cells (due to altered T- cell production of cytokines or intrinsic B-cell defect) The levels of other immunoglobulins are usually normal or even excess
  • 9. Hyper-IgM Syndrome • X-linked disorder - due to a defect in isotype class switchover of B cells • Mutations in either CD40L or CD40 genes, leading to prevention of interaction between T and B-cell ; thus blocking the class switchover • Block in class switchover results in lack of synthesis of other classes of antibodies - IgG, IgA, and IgE with a normal or supernormal levels of IgM • Deficiency of IgG – leads to defect in opsonization and complement activation (predisposes to recurrent pyogenic infections)
  • 10. Hyper-IgM Syndrome • IgA deficiency leads to increased recurrent sinopulmonary infections and diarrhea • Excess IgM antibodies can react with blood cells, resulting in autoimmune hemolytic anemia, thrombocytopenia, or neutropenia • Patients with defect in CD40L are more susceptible to Pneumocystis jirovecii infection
  • 11. DiGeorge Syndrome (Thymic Aplasia) • Results from a congenital defect in thymic development leading to defect in T-cell maturation • Infants are extremely vulnerable to viral, fungal, intracellular bacterial and protozoan infections • Pathogenesis- In 90% of cases, there occurs a deletion affecting chromosome 22q11 which leads to developmental malformation affecting the third and fourth pharyngeal pouches in embryonic life • Thymus, parathyroid glands, and portions of the face and aortic arch become defective
  • 12. DiGeorge Syndrome (Thymic Aplasia) • There may be associated: Parathyroid gland hypoplasia resulting in neonatal tetany and hypocalcemia Anomalies of the heart and the great vessels (Fallot's Tetralogy) Characteristic facial appearance • Treatment- Thymus transplantation has been found to be successful in restoration of immune function. In others (with partial defects), immunity may improve spontaneously with age
  • 14. Chronic Mucocutaneous Candidiasis • Represents an impaired cell-mediated immunity against Candida albicans leads to superficial infections of the skin, mucous membranes, and nails • Do not show increased susceptibility to other infections but often associated with endocrinopathies and autoimmune disorders (vitiligo, malabsorption syndromes) • Transfer factor therapy, along with fluconazole has been reported to be effective
  • 15. Severe Combined Immunodeficiencies (SCID) • Represents groups of genetically distinct syndromes; all having in common, defects in both humoral and cell-mediated immune responses • Severe: implies complete absence of T cell function, death in first year • Mutation in cytokine receptor - Approximately 50-60% of the cases of SCID are X-linked (seen in males) • Results from mutations in the gene encoding the common γ chain shared by the cytokine receptors for IL-7 and others (IL-2, IL-4, IL-9, and IL-15) • Defective IL-7 receptor - defect in survival and expansion of immature B- and T-cell precursors in the bone marrow • Defect in IL-15 receptor - deficiency of NK cell
  • 16. Types of SCID • Adenosine deaminase (ADA) deficiency - Most common, ADA deficiency leads to accumulation of deoxyadenosine which is toxic to rapidly dividing immature T lymphocytes • RAG Mutation- Recombinase-activating genes (RAG) defect blocks the development of T and B cells • Jak3 mutation- Jak3, an intracellular kinase mutation is another way of blocking the cytokine receptor signalling • Class II MHC deficiency-Mutations that impair the expression of class II MHC molecules prevent the development of CD4+ T cells. This condition is also called the bare lymphocyte syndrome
  • 17. SCID • Affected infants are susceptible to severe recurrent infections by a wide array of pathogens, including Candida, Pneumocystis, cytomegalovirus, and Pseudomonas • Bone marrow transplantation. Gene therapy replacing the mutated genes has been successful in X linked cases
  • 18. Wiskott–Aldrich Syndrome (WAS) • X-linked recessive disease • Characterized by immunodeficiency with thrombocytopenia, eczema(triad) • Severity of WAS increases with age • First manifests itself by defective responses to bacterial polysaccharides and by lower IgM levels. IgG levels are usually normal Paradoxically the levels of IgA and IgE are often elevated • Other T and B cell responses are normal initially, but with increase of age, there are recurrent bacterial infections and a gradual loss of humoral and cellular responses • Prone to develop non-Hodgkin B-cell lymphomas • Bloody diarrhea secondary to thrombocytopenia
  • 19. Wiskott–Aldrich Syndrome (WAS) • Pathogenesis: Genetic defect is due to a mutation in the gene encoding Wiskott-Aldrich syndrome protein (WASP) present in precursor lymphoid cells of bone marrow Cytoskeletal glycoprotein (sialophorin or CD43), required for actin polymerization
  • 20. Ataxia Telangiectasia • Difficulty in maintaining balance while walking (cerebellar ataxia) • Appearance of broken capillaries (telangiectasia) in the eyes and choreoathetoid movements (usually noticed in infancy) • Deficiency of IgA and sometimes IgE • Profound sinopulmonary infections • Primary defect - kinase involved in regulation of the cell cycle
  • 21. Nezelof Syndrome • Autosomal recessive • Cellular immunodeficiency resulting from thymus hypoplasia • In some patients, B cells are normal, whereas in others a B-cell deficiency is secondary to the T-cell defect • Affected individuals suffer from chronic diarrhea, viral and fungal infections, and a general failure to thrive
  • 22. Chronic Granulomatous Disease (CGD) • Pathogenesis: Involves inherited defects in the gene encoding components of oxidase system E.g. Nicotinamide adenine dinucleotide phosphate (NADP) oxidase of phagocyte which breaks down hydrogen peroxide to generate free oxygen radicals (O2 -) that are involved in microbial killing Decreased oxidative burst which predisposes to recurrent bacterial infections. CGD is a genetic disease that runs in family in two forms • X linked form (more common, 70%) - membrane component of phagocyte oxidase is defective • Autosomal recessive form- cytoplasmic component of phagocyte oxidase is defective
  • 23. Chronic Granulomatous Disease (CGD) • Manifestations- Bacteria involved in the recurrent infections are catalase positive; pyogenic pathogens such as staphylococci, Pseudomonas and coliforms Excessive inflammatory reactions that result in gingivitis, swollen lymph nodes, and non-malignant granulomas (lumpy subcutaneous cell masses) Nitroblue tetrazolium reduction test (NBT) is used for screening to detect deficiency of NADPH oxidase activity
  • 24. Myeloperoxidase Deficiency • Common genetic disorder characterized by deficiency in either quantity or function, of myeloperoxidase, an enzyme produced by neutrophils • Patients present with immune deficiency and recurrent infections, especially with Candida albicans
  • 25. Chediak–Higashi Syndrome • Autosomal recessive disease • Defective fusion of phagosomes and lysosomes in phagocytes which leads to increased susceptibility to recurrent and severe pyogenic infections • Abnormalities in melanocytes leading to albinism (lack of skin and eye pigment) • Abnormalities in cells of the nervous system (associated with nerve defects), and • Platelets abnormalities, causing bleeding disorders • Aggressive but non-malignant infiltration of organs by lymphoid cells
  • 26. Chediak–Higashi Syndrome • Pathogenesis: Mutation in a protein called LYST (regulate lysosomal trafficking)  Impairs the targeting of proteins to secretory lysosomes, which makes them unable to lyse bacteria  Phagocytes from patients with this immune defect contain giant granules but do not have the ability to kill bacteria
  • 27. Leukocyte Adhesion Deficiency (LAD) • Rare autosomal recessive disorder, characterized by a defect in the adhesion of leukocytes which results in poor leukocyte chemotaxis particularly of neutrophils • Predisposes to various bacterial and fungal infections • Due to mutations in β2 integrin subunit (CD18) of the leukocyte cell adhesion molecule or fucosyltransferase enzyme
  • 28. Lazy Leukocyte Syndrome • Idiopathic condition due to defect in neutrophil chemotaxis • Increased pyogenic infections such as gingivitis, abscess formation, pneumonia and neutropenia
  • 29. Job’s Syndrome (Hyper-IgE Syndrome) • Hyper-IgE syndrome - rare primary immunodeficiency disease characterized by eczema, recurrent staphylococcal skin abscesses, recurrent lung infections (pneumatocele), eosinophilia and high serum levels of IgE • Underlying mechanism - defect in neutrophil chemotaxis; due to mutations in STAT3 or DOCK8 genes
  • 30. SECONDARY IMMUNODEFICIENCIES • Secondary effects of other diseases such as- Malnutrition (due to inadequate immunoglobulin synthesis) Aging (suppression of immune system with age) Patients with several infections that supresses immune system causing lymphocyte depletion, e.g. HIV (human immunodeficiency virus) infection. Underlying cancers (particularly those of the bone marrow and blood cells (leukemia, lymphoma, multiple myeloma) Underlying proteinuric renal diseases– leads to loss of immunoglobulins Sarcoidosis Patients on immunosuppressive medications Patients receiving chemotherapy or radiation therapy for malignancy
  • 31.
  • 32.
  • 33. Pathogen Type T-Cell Defect B-Cell Defect Granulocyte Defect Complement Defect Bacteria Bacterial sepsis Streptococci, Staphylococci, Haemophilus influenzae Staphylococci, Pseudomonas Nocardia Neisseria, Other pyogenic infections Viruses Cytomegalovirus, Epstein-Barr virus, Severe varicella, Chronic infections with respiratory and intestinal viruses Enterovirus encephalitis - Fungi Candida, Pneumocystis - Candida, Aspergillus
  • 34. Pathogen Type T-Cell Defect B-Cell Defect Granulocyte Defect Complement Defect Parasites - Giardiasis - Special features Aggressive disease with opportunistic pathogens, failure to clear infections Recurrent sinopulmonary infections, Sepsis, chronic meningitis -
  • 35. Case1 • 42 / male from Balrampur, Uttar Pradesh was cough and breathlessness since 6 months • He had a history of taking anti tubercular therapy 15 years ago but there was no documentation • He had no history of COVID-19 illness • There was no history of diabetes,hypertension, ischaemic heart disease • Patient was smoker for 20 years,quit smoking 5 years ago • He is farmer by occupation • CT guided biopsy of the mass lesion (done on 1/7/22) was done outside and was suggestive of fungal granuloma , while work up for TB was negative • Patent was initiated on empirical anti-fungals (Fluconazole 400mg/day); which he has taken for 4 months- however there is no clinic-radiological improvement. He was thus referred to Dept. of Pulmonary Medicine at our hospital
  • 36. Figure showing CT Thorax- homogenous soft tissue lesion in the right upper lobe, right middle lobe, and superior segment of RLL with non enhancing necrotic component Figure showing Chest Xray with lobulated spiculated mass covering upper and middle lobe
  • 37. Work up • Repeat CT guided biopsy was done and the biopsy sample was sent to microbiology department for further confirmation • Mycobacterium tuberculosis complex was not detected by GeneXpert Assay. ZN stain was negative for acid fast bacilli. Culture for tuberculosis was also negative • 10% KOH wet shows plenty of tissue debris and plenty capsulated round budding yeast suggestive of Cryptococcus spp • Grams’s stain also showed 5-10 micrometer round double walled spherical structures with gram positive stippling suggestive of Cryptococcus spp • However culture was negative after 6 weeks of incubation
  • 38. Figure showing 10% KOH preparation of lung tissue round yeast cells(yellow arrow) Figure showing Gram’s stain- 5-10 micrometer round double walled spherical structures with gram positive stippling (yellow arrow)
  • 39. Figure showing cryptococcal antigen from lung tissue sample with titre 1:8
  • 40. Further Work up • HIV 1 and 2- Not detected • HbsAg- Not detected • Anti HCV-Not detected • Serum IgA-324 mg/dl (Normal range 90-450 mg/dl) • Serum IgE- 1799 iu/ml • Serum IgM- 82.3 mg/dl (Normal range 60-280 mg/dl) • Serum IgG= 1630 mg/dl (Normal range 800-1800 mg/dl)
  • 41.
  • 42. • His absolute CD4 count was 173 per cmm. Suggestive of CD4 lymphopenia • Final Diagnosis- Lung mass caused by Cryptococcus spp in a patient of isolated CD4 lymphopenia.
  • 43. • Total Duration of Illness – 2 years • Dec 2020: Fever, cough for 1 week • Jan 2021: Fever, cough, shoertness of breath treated as pneumonia with IV antibiotic for 1 month(Needed hospital admission) • Oct 2021: Fever, cough – admitted and treated 1 week • Dec 2021: Petechial rash over bilateral hands, chest, abdomen, no h/o mucosal lesions, reduced platelet. No platelet transfusion was given. Symptoms resolved in 4 days • April 2022: Fever, with raised TLC around 24000, Treated for 2 days. Hb 7. Platelet – 33k. 1 PRBC was transfused • June 2022: 3 platelets transfused. BMA – Congenital amegakaryocytic thrombocytopenia • Aug-Sept 2022: On oral folate, • Oct 2022: Thrombocytopenia, PLT – 33k. TLC 50,000. TLC 26000, L 88, N8 • Two of his sibling died
  • 44. Further Work up • HIV 1 and 2- Not detected • HbsAg- Not detected • Anti HCV-Not detected • Serum IgA-6.67 mg/dl (Normal range 90-450 mg/dl) • Serum IgE- 5 iu/ml • Serum IgM- 4.17 mg/dl (Normal range 60-280 mg/dl) • Serum IgG= 33.3 mg/dl (Normal range 800-1800 mg/dl)
  • 45. • Total lymphocytes: 68%, • T cell- 97%, B cell - 0.01%, NK cell - 2%, • Of the CD3+ T Cells:- CD4 positive T cells: 3%, CD8 Pos T Cells: 86%, DNTs- 11%. CD4:CD8 ratio is 1:29
  • 46.
  • 47. Case 3 • 27/ M from a site manager of fertilizer unit • TDI – 2 yrs • Aug 2020: Weight loss 1 yr – 13 kg, fever low grade 3 months, night sweats, abdominal pain • Started on emperical ATT (outside) • ill defines hypodense lesions in spleen, minimal ascites, retroperitoneal lymphadenopathy • Patient started feeling well on ATT , fever resolved, there was weight gain • July 2021: Completed ATT for 1 yr
  • 48. Present illness • Nov 2022: 1 month history of cough with expectoration, myalgia, fever low grade with loose stool for for 15 days • CT thorax – multilobar bronchial wall thickening and mild dilatation with clusters of branching centrilobular nodules in bilateral lower lobes • Multiple mediastinal, para tracheal and mesenteric nodes present
  • 49. Course in SGPGIMS • Admitted in SGPGIMS as a case of pneumonia • He had leukopenia of 1900, ANC – 900 • Emperically started on cefoperazone- sulbactum and Teicoplanin • He was afebrile after 3 days • His sputum revealed Pseudomonas aeruninosa • Gene Xpert sputum negative • His lungs were clear. No active sputum or fever • Hence Bone marrow analysis was done – BMA & Biopsy normal • Stool examination- Giardia sp
  • 50. Lymphocyte subset analysis • low B cell count, normal NK, CD4, CD8, total T cell count
  • 51. Further Work up • HIV 1 and 2- Not detected • HbsAg- Not detected • Anti HCV-Not detected • Serum IgA-6.67 mg/dl (Normal range 90-450 mg/dl) • Serum IgE- 5 iu/ml • Serum IgM- 8.08 mg/dl (Normal range 60-280 mg/dl) • Serum IgG= 33.3 mg/dl (Normal range 800-1800 mg/dl)
  • 52. • Final diagnosis- Common variable immunodeficiency

Editor's Notes

  1. Mutations in the BTK gene are implicated in the primary immunodeficiency disease X-linked agammaglobulinemia (Bruton's agammaglobulinemia); sometimes abbreviated to XLA and selective IgM deficiency.[8] Patients with XLA have normal pre-B cell populations in their bone marrow but these cells fail to mature and enter the circulation. The Btk gene is located on the X chromosome (Xq21.3-q22).[9] At least 400 mutations of the BTK gene have been identified. Of these, at least 212 are considered to be disease-causing mutations.[
  2. It is not recommended and dangerous for XLA patients to receive live attenuated vaccines such as live polio, or the measles, mumps, rubella (MMR vaccine).[3] Special emphasis is given to avoiding the oral live attenuated SABIN-type polio vaccine that has been reported to cause polio to XLA patients. Furthermore, it is not known if active vaccines in general have any beneficial effect on XLA patients as they lack normal ability to maintain immune memory.
  3. A normal CD4/CD8 ratio is greater than 1.0, with CD4 lymphocytes ranging from 500 to 1200/mm 3 and CD8 lymphocytes ranging from 150 to 1000/mm 3
  4. Immunoglobulin class switching, also known as isotype switching, isotypic commutation or class-switch recombination (CSR), is a biological mechanism that changes a B cell's production of immunoglobulin from one type to another, such as from the isotype IgM to the isotype IgG During this process, the constant-region portion of the antibody heavy chain is changed, but the variable region of the heavy chain stays the same (the terms variable and constant refer to changes or lack thereof between antibodies that target different epitopes). Since the variable region does not change, class switching does not affect antigen specificity. Instead, the antibody retains affinity for the same antigens, but can interact with different effector molecules.
  5. Salient features can be summarized using the mnemonic CATCH-22 to describe 22q11.2DS, with the 22 signifying the chromosomal abnormality is found on the 22nd chromosome, as below:[17] Cardiac abnormality (commonly interrupted aortic arch, truncus arteriosus and tetralogy of Fallot) Abnormal facies Thymic aplasia or hypoplasia Cleft palate Hypocalcemia/hypoparathyroidism early in life
  6. Transfer factors are essentially small immune messenger molecules that are produced by all higher organisms.[1] Transfer factors were originally described as immune molecules that are derived from blood or spleen cells that cause antigen-specific cell-mediated immunity, primarily delayed hypersensitivity and the production of lymphokines, as well as binding to the antigens themselves. They have a molecular weight of approximately 5000 Daltons and are composed entirely of amino acids. The mechanism the human immune system has is normally to fight an infection (like Candida). Initially, Th17 cells are made by the immune system, which in turn produces interleukin-17 (IL-17). This induces inflammation and white blood cells confront infection.[9] Chronic mucocutaneous candidiasis mutations affect IL-17 by inhibiting its pathway. This in turn affects the human immune system's ability to fight infection, in total there are 9 possible types of this condition
  7. Most common SCID Is X linked SCID 40-50% of SCID
  8. Adenosine deaminase (also known as adenosine aminohydrolase, or ADA) is an enzyme  involved in purine metabolism. It is needed for the breakdown of adenosine from food and for the turnover of nucleic acids in tissues. ADA irreversibly deaminates adenosine, converting it to the related nucleoside inosine by the substitution of the amino group by a keto group. Adenosine Inosine Inosine can then be deribosylated (removed from ribose) by another enzyme called purine nucleoside phosphorylase (PNP), converting it to hypoxanthine.
  9. WASP protein is expressed exclusively in cytoplasm of hematopoetic cell Required for actin cytoskeleton remodelling In the absence, cause defective formation of immunological synapse (required for lipid rafts
  10. Nezelof syndrome is an autosomal recessive[6] congenital immunodeficiency condition due to underdevelopment of the thymus. The defect is a type of purine nucleoside phosphorylase deficiency with inactive phosphorylase, this results in an accumulation of deoxy-GTP which inhibits ribonucleotide reductase. Ribonucleotide reductase catalyzes the formation of deoxyribonucleotides from ribonucleotides, thus, DNA replication is inhibited.
  11. The nitroblue-tetrazolium (NBT) test i-It is negative in CGD, meaning that it does not turn blue. The higher the blue score, the better the cell is at producing reactive oxygen species. This test depends upon the direct reduction of NBT to the insoluble blue compound formazan by superoxide which is produced by normal peripheral blood neutrophils stimulated in vitro; NADPH oxidase catalyzes the aforementioned reaction and NADPH is oxidized in the same reaction. This test is simple to perform and gives rapid results but only tells whether or not there is a problem with the PHOX enzymes, not how much they are affected.[citation needed]
  12. Phagocytes (i.e. neutrophils and macrophages) require an enzyme to produce reactive oxygen species to destroy bacteria after they are ingested (phagocytosis), a process known as the respiratory burst. This enzyme is termed "phagocyte NADPH oxidase" (PHOX). This enzyme oxidizes NADPH and reduces molecular oxygen to produce superoxide anions, a reactive oxygen species. Superoxide is then disproportionated into peroxide and molecular oxygen by superoxide dismutase. Finally, peroxide is used by myeloperoxidase to oxidize chloride ions into hypochlorite (the active component of bleach), which is toxic to bacteria. Thus, NADPH oxidase is critical for phagocyte killing of bacteria through reactive oxygen species.[citation needed] (Two other mechanisms are used by phagocytes to kill bacteria: nitric oxide and proteases, but the loss of ROS-mediated killing alone is sufficient to cause chronic granulomatous disease.)[